Recombinant activity-dependent neuroprotective protein protects cells against oxidative stress

Molecular and Cellular Endocrinology

Volumn 252, Issue 1-2, 2006, Pages 148-153

  Steingart, R A ^a   Gozes, I ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Amyloid 25 35; Activity dependent neuroprotective protein (ADNP); Neuroprotection; Oxidative stress; P53; Pheochromocytoma (PC12)

Indexed keywords

COMPLEMENTARY DNA; HYDROGEN PEROXIDE; PROTEIN P53; PROTEIN VP22; RECOMBINANT ACTIVITY DEPENDENT NEUROPROTECTIVE PROTEIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARCUATE NUCLEUS; ARTICLE; CELL MEMBRANE; CELL PROTECTION; CLONING; ESTRUS CYCLE; INCUBATION TIME; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT;

AMYLOID; ANIMALS; CLONING, MOLECULAR; HOMEODOMAIN PROTEINS; NERVE TISSUE PROTEINS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PC12 CELLS; RATS; RECOMBINANT FUSION PROTEINS; VIRAL STRUCTURAL PROTEINS;

EID: 33745223638     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2006.03.029     Document Type: Article

References (34)

1. Bassan M., Zamostiano R., Davidson A., Pinhasov A., Giladi E., Perl O., Bassan H., Blat C., Gibney G., Glazner G., Brenneman D.E., and Gozes I. Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide. J. Neurochem. 72 (1999) 1283-1293
2. Beni-Adani L., Gozes I., Cohen Y., Assaf Y., Steingart R.A., Brenneman D.E., Eizenberg O., Trembolver V., and Shohami E. A peptide derived from activity-dependent neuroprotective protein ADNP ameliorates injury response in closed head injury in mice. J. Pharmacol. Exp. Ther. 296 (2001) 57-63
3. Blondel O., Collin C., McCarran W.J., Zhu S., Zamostiano R., Gozes I., Brenneman D.E., and McKay R.D. A glia-derived signal regulating neuronal differentiation. J. Neurosci. 20 (2000) 8012-8020
4. Bredesen D.E. Neural apoptosis. Ann. Neurol. 38 (1995) 839-851
5. Brenneman D.E., and Gozes I. A femtomolar-acting neuroprotective peptide. J. Clin. Invest. 97 (1996) 2299-2307
6. Brenneman D.E., Phillips T.M., Hauser J., Hil J.M., Spong C.Y., and Gozes I. Complex array of cytokines released by vasoactive intestinal peptide. Neuropeptides 37 (2003) 111-119
7. Chopp M., Li Y., Zhang Z.G., and Freytag S.O. p53 expression in brain after middle cerebral artery occlusion in the rat. Biochem. Biophys. Res. Commun. 182 (1992) 1201-1207
8. Culmsee C., Zhu X., Yu Q.S., Chan S.L., Camandola S., Guo Z., Greig N.H., and Mattson M.P. A synthetic inhibitor of p53 protects neurons against death induced by ischemic and excitotoxic insults, and amyloid beta-peptide. J. Neurochem. 77 (2001) 220-228
9. de la Monte S.M., Sohn Y.K., and Wands J.R. Correlates of p53- and Fas CD95-mediated apoptosis in Alzheimer's disease. J. Neurol. Sci. 152 (1997) 73-83
10. Furman S., Steingart R.A., Nadel S., Hauser J.M., Brenneman D.E., and Gozes I. Subcellular localization and secretion of activity-dependent neuroprotective protein in astrocytes. Neuron Glia Biol. 1 (2004) 139-199
11. Furman S., Hill J.M., Vulih I., Zaltzman R., Hauser J.M., Brenneman D.E., and Gozes I. Sexual dimorphism of activity-dependent neuroprotective protein in the mouse arcuate nucleus. Neurosci. Lett. 373 (2005) 73-78
12. Gozes I., Bassan M., Zamostian R., Pinhasov A., Davidson A., Giladi E., Perl O., Glazner G.W., and Brenneman D.E. A novel signaling molecule for neuropeptide action: activity-dependent neuroprotective protein. Ann. N.Y. Acad. Sci. 897 (1999) 125-135
13. Gozes I., Steingart R., and Spier A.D. NAP mechanisms of neuroprotection. J. Mol. Neurosci. 24 (2004) 67-72
14. Gozes I., Zamostiano R., Pinhasov A., Bassan M., Giladi E., Steingart R.A., and Brenneman D.E. A novel VIP responsive gene. Activity dependent neuroprotective protein. Ann. N.Y. Acad. Sci. 921 (2000) 115-118
15. Leker R.R., Teichner A., Grigoriadis N., Ovadia H., Brenneman D.E., Fridkin M., Giladi E., Romano J., and Gozes I. NAP, a femtomolar-acting peptide, protects the brain against ischemic injury by reducing apoptotic death. Stroke 33 (2002) 1085-1092
16. Levers T.E., Edgar J.M., and Price D.J. The fates of cells generated at the end of neurogenesis in developing mouse cortex. J. Neurobiol. 48 (2001) 265-277
17. Lin L.F., Doherty D.H., Lile J.D., Bektesh S., and Collins F. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 605111 (1993) 1130-1132
18. Maizel A., Tassetto M., Filhol O., Cochet C., Prochiantz A., and Joliot A. Engrailed homeoprotein secretion is a regulated process. Development 129 (2002) 3545-3553
19. Morrison R., Kinoshita Y., Johnson M.D., Gue W., and Garden G.A. p53- dependent cell death signaling in neurons. Neurochem. Res. 25 (2003) 15-27
20. Napieralski J.A., Raghupathi, and McIntosh T.K. The tumor-suppressor gene, p53, is induced in injured brain regions following experimental traumatic brain injury. Brain Res. Mol. Brain Res. 71 (1999) 78-96
21. Offen D., Sherki Y., Melamed E., Fridkin M., Brenneman D.E., and Gozes I. Vasoactive intestinal peptide VIP prevents neurotoxicity in neuronal cultures: relevance to neuroprotection in Parkinson's disease. Brain Res. 854 (2000) 257-262
22. Petrova P., et al. MANF: a new mesencephalic, astrocyte-derived neurotrophic factor with selectivity for dopaminergic neurons. J. Mol. Neurosci. 20 (2003) 173-188
23. Pinhasov A., Mandel S., Torchinsky A., Giladi E., Pittel Z., Goldsweig A.M., Servoss S.J., Brenneman D.E., and Gozes I. Activity-dependent neuroprotective protein: a novel gene essential for brain formation. Dev. Brain Res. 144 (2003) 83-90
24. Poggi S.H., Vink J., Goodwin K., Hill J.M., Brenneman D.E., Pinhasov A., Gozes I., and Spong C.Y. Differential expression of embryonic and maternal activity-dependent neuroprotective protein during mouse development. Am. J. Obstet. Gynecol. 187 (2002) 973-976
25. Qian C., Sangro B., and Prieto J. New strategies to enhance gene therapy efficiency. Gastroenterology 23 (2002) 639-642
26. Romano J., Beni-Adani L., Nissenbaum O.L., Brenneman D.E., Shohami E., and Gozes I. A single administration of the peptide NAP induces long-term protective changes against the consequences of head injury: gene Atlas array analysis. J. Mol. Neurosci. 18 (2002) 37-45
27. Roy I., Holle L., Song W., Holle E., Wagner T., and Yu X. Efficient translocation and apoptosis induction by adenovirus encoded VP22-p53 fusion protein in human tumor cells in vitro. Anticancer Res. 226A (2002) 3185-3189
28. Steingart R.A., Heldenberg E., Pinhasov A., Brenneman D.E., Fridkin M., and Gozes I. A vasoactive intestinal peptide receptor analog alters the expression of homeobox genes. Life Sci. 71 (2002) 2543-2552
29. Steingart R.A., Solomon B., Brenneman D.E., Fridkin M., and Gozes I. VIP and peptides related to activity-dependent neurotrophic factor protect PC12 cells against oxidative stress. J. Mol. Neurosci. 15 (2000) 137-145
30. Tamagno E., Parola M., Guglielmotto M., Santoro G., Bardini P., Marra L., Tabaton M., and Danni O. Multiple signaling events in amyloid beta-induced, oxidative stress-dependent neuronal apoptosis. Free Radic. Biol. Med. 35 (2003) 45-58
31. 2, caspase-3, NF-kappaB, p53 and c-Jun. Neurotoxicology 23 (2002) 351-365
32. Zamostiano R., Pinhasov A., Gelber E., Steingart R.A., Seroussi E., Giladi E., Bassan M., Wollman Y., Eyre H.J., Mulley J.C., Brenneman D.E., and Gozes I. Cloning and characterization of the human activity-dependent neuroprotective protein. J. Biol. Chem. 276 (2001) 708-714
33. Zaltzman R., Alexandrovich A., Trembovler V., Shohami E., and Gozes I. The influence of the peptide NAP on Mac-1-deficient mice following closed head injury. Peptides 26 (2005) 1520-1527 (Epub 2005 Apr 15)
34. Zemlyak I., Furman S., Brenneman D.E., and Gozes I. A novel peptide prevents death in enriched. Regul. Peptides 96 (2000) 39-43